SPARROW PHARMACEUTICALS Trademark

Trademark Overview


On Friday, April 9, 2021, a trademark application was filed for SPARROW PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SPARROW PHARMACEUTICALS trademark a serial number of 90635886. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 17, 2023. This trademark is owned by Sparrow Pharmaceuticals, Inc.. The SPARROW PHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of allergic states, collagen diseases, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematological disorders, infectious diseases, neoplastic diseases, nervous system disorders, ophthalmic diseases, respiratory disorders, and rheumatic disorders

providing health information via a website; providing information to patients in the field of administering medications; providing medical information from a web site
sparrow pharmaceuticals

General Information


Serial Number90635886
Word MarkSPARROW PHARMACEUTICALS
Filing DateFriday, April 9, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the terms SPARROW PHARMACEUTICALS to the right of a stylized design of a bird with three triangles in the form of the bird's feathers.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of allergic states, collagen diseases, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematological disorders, infectious diseases, neoplastic diseases, nervous system disorders, ophthalmic diseases, respiratory disorders, and rheumatic disorders
Goods and Servicesproviding health information via a website; providing information to patients in the field of administering medications; providing medical information from a web site
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 17, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSparrow Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPortland, OR 97204

Trademark Events


Event DateEvent Description
Wednesday, May 17, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 17, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, May 17, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, September 27, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 27, 2022FINAL REFUSAL E-MAILED
Tuesday, September 27, 2022FINAL REFUSAL WRITTEN
Thursday, August 11, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, August 11, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 11, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, August 11, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, July 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NON-FINAL ACTION WRITTEN
Friday, May 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 26, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 29, 2021NON-FINAL ACTION E-MAILED
Monday, November 29, 2021NON-FINAL ACTION WRITTEN
Monday, November 29, 2021ASSIGNED TO EXAMINER
Tuesday, July 20, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, July 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 13, 2021NEW APPLICATION ENTERED